1887

Abstract

Ocular herpes simplex virus type 1 (HSV-1) infection elicits a strong inflammatory response that is associated with production of the chemokines CCL3 and CCL5, which share a common receptor, CCR5. To gain insight into the role of these molecules in ocular immune responses, the corneas of wild-type (WT) and CCR5-deficient (CCR5−/−) mice were infected with HSV-1 and inflammatory parameters were measured. In the absence of CCR5, the early infiltration of neutrophils into the cornea was diminished. Associated with this aberrant leukocyte recruitment, neutrophils in CCR5−/− mice were restricted to the stroma, whereas in WT mice, these cells trafficked to the stroma and epithelial layers of the infected cornea. Virus titres and cytokine/chemokine levels in the infected tissue of these mice were similar for the first 5 days after infection. However, by day 7 post-infection, the CCR5−/− mice showed a significant elevation in the chemokines CCL2, CCL5, CXCL9 and CXCL10 in the trigeminal ganglion and brainstem, as well as a significant increase in virus burden. The increase in chemokine expression was associated with an increase in the infiltration of CD4 and/or CD8 T cells into the trigeminal ganglion and brainstem of CCR5−/− mice. Surprisingly, even though infected CCR5−/− mice were less efficient at controlling the progression of virus replication, there was no difference in mortality. These results suggest that, although CCR5 plays a role in regulating leukocyte trafficking and control of virus burden, compensatory mechanisms are involved in preventing mortality following HSV-1 infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81339-0
2006-03-01
2019-11-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/3/489.html?itemId=/content/journal/jgv/10.1099/vir.0.81339-0&mimeType=html&fmt=ahah

References

  1. Algood, H. M. S. & Flynn, J. L. ( 2004; ). CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol 173, 3287–3296.[CrossRef]
    [Google Scholar]
  2. Appay, V. & Rowland-Jones, S. L. ( 2001; ). RANTES: a versatile and controversial chemokine. Trends Immunol 22, 83–87.[CrossRef]
    [Google Scholar]
  3. Banerjee, K., Biswas, P. S., Kim, B., Lee, S. & Rouse, B. T. ( 2004; ). CXCR2−/− mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol 172, 1237–1245.[CrossRef]
    [Google Scholar]
  4. Belnoue, E., Kayibanda, M., Deschemin, J. C., Viguier, M., Mack, M., Kuziel, W. A. & Renia, L. ( 2003; ). CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood 101, 4253–4259.[CrossRef]
    [Google Scholar]
  5. Biswas, P. S., Banerjee, K., Kim, B. & Rouse, B. T. ( 2004; ). Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. J Immunol 172, 3736–3744.[CrossRef]
    [Google Scholar]
  6. Buch, S., Sui, Y., Dhillon, N. & 11 other authors ( 2004; ). Investigations on four host response factors whose expression is enhanced in X4 SHIV encephalitis. J Neuroimmunol 157, 71–80.[CrossRef]
    [Google Scholar]
  7. Carr, D. J. J., Chodosh, J., Ash, J. & Lane, T. E. ( 2003; ). Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol 77, 10037–10046.[CrossRef]
    [Google Scholar]
  8. Dawson, T. C., Beck, M. A., Kuziel, W. A., Henderson, F. & Maeda, N. ( 2000; ). Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156, 1951–1959.[CrossRef]
    [Google Scholar]
  9. De Lemos, C., Christensen, J. E., Nansen, A., Moos, T., Lu, B., Gerard, C., Christensen, J. P. & Thomsen, A. R. ( 2005; ). Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice. J Immunol 175, 1767–1775.[CrossRef]
    [Google Scholar]
  10. Gasperini, S., Marchi, M., Calzetti, F. & 7 other authors ( 1999; ). Gene expression and production of the monokine induced by IFN-γ (MIG), IFN-inducible T cell α chemoattractant (I-TAC), and IFN-γ-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 162, 4928–4937.
    [Google Scholar]
  11. Ghiasi, H., Cai, S., Perng, G.-C., Nesburn, A. B. & Wechsler, S. L. ( 2000; ). Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br J Ophthalmol 84, 408–412.[CrossRef]
    [Google Scholar]
  12. Glass, W. G. & Lane, T. E. ( 2003; ). Functional expression of chemokine receptor CCR5 on CD4+ T cells during virus-induced central nervous system disease. J Virol 77, 191–198.[CrossRef]
    [Google Scholar]
  13. Glass, W. G., Hickey, M. J., Hardison, J. L., Liu, M. T., Manning, J. E. & Lane, T. E. ( 2004; ). Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol 172, 4018–4025.[CrossRef]
    [Google Scholar]
  14. Harland, J. & Brown, S. M. ( 1998; ). HSV growth, preparation, and assay. In Methods in Molecular Medicine – Herpes Simplex Virus Protocols, pp. 1–8. Edited by S. M. Brown & A. R. MacLean. Totowa, NJ: Humana Press.
  15. He, J., Ichimura, H., Iida, T. & 7 other authors ( 1999; ). Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL/6 mice after corneal HSV-1 infection. J Interferon Cytokine Res 19, 609–615.[CrossRef]
    [Google Scholar]
  16. Huang, D., Tani, M., Wang, J. & 7 other authors ( 2002; ). Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. J Neurosci 15, 10633–10642.
    [Google Scholar]
  17. Huffnagle, G. B., McNeil, L. K., McDonald, R. A., Murphy, J. W., Toews, G. B., Maeda, N. & Kuziel, W. A. ( 1999; ). Cutting edge: role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol 163, 4642–4646.
    [Google Scholar]
  18. Kalehua, A. N., Nagel, J. E., Whelchel, L. M., Gides, J. J., Pyle, R. S., Smith, R. J., Kusiak, J. W. & Taub, D. D. ( 2004; ). Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration. Exp Cell Res 297, 197–211.[CrossRef]
    [Google Scholar]
  19. Kurt-Jones, E. A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., Arnold, M. M., Knipe, D. M. & Finberg, R. W. ( 2004; ). Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A 101, 1315–1320.[CrossRef]
    [Google Scholar]
  20. Kuziel, W. A., Dawson, T. C., Quinones, M., Garavito, E., Chenaux, G., Ahuja, S. S., Reddick, R. L. & Maeda, N. ( 2003; ). CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis 167, 25–32.[CrossRef]
    [Google Scholar]
  21. Lane, T. E., Liu, M. T., Chen, B. P. & 7 other authors ( 2000; ). A central role for CD4+ T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 74, 1415–1424.[CrossRef]
    [Google Scholar]
  22. Laudanna, C., Kim, J. Y., Constantin, G. & Butcher, E. ( 2002; ). Rapid leukocyte integrin activation by chemokines. Immunol Rev 186, 37–46.[CrossRef]
    [Google Scholar]
  23. Lee, S., Zheng, M., Kim, B. & Rouse, B. T. ( 2002; ). Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 110, 1105–1111.[CrossRef]
    [Google Scholar]
  24. Liu, T., Tang, Q. & Hendricks, R. L. ( 1996; ). Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol 70, 264–271.
    [Google Scholar]
  25. Lundberg, P., Welander, P., Han, X. & Cantin, E. ( 2003; ). Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo. J Virol 77, 11158–11169.[CrossRef]
    [Google Scholar]
  26. Luster, A. D. ( 1998; ). Chemokines – chemotactic cytokines that mediate inflammation. N Engl J Med 338, 436–445.[CrossRef]
    [Google Scholar]
  27. Mack, M., Cihak, J., Simonis, C. & 10 other authors ( 2001; ). Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol 166, 4697–4704.[CrossRef]
    [Google Scholar]
  28. Melchjorsen, J., Pedersen, F. S., Mogensen, S. C. & Paludan, S. R. ( 2002; ). Herpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and IP10. J Virol 76, 2780–2788.[CrossRef]
    [Google Scholar]
  29. Roberts, E. S., Burudi, E. M., Flynn, C., Madden, L. J., Roinick, K. L., Watry, D. D., Zandonatti, M. A., Taffe, M. A. & Fox, H. S. ( 2004; ). Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol 157, 81–92.[CrossRef]
    [Google Scholar]
  30. Rollins, B. J. ( 1997; ). Chemokines. Blood 90, 909–928.
    [Google Scholar]
  31. Shimeld, C., Whiteland, J. L., Nicholls, S. M., Grinfeld, E., Easty, D. L., Gao, H. & Hill, T. J. ( 1995; ). Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J Neuroimmunol 61, 7–16.[CrossRef]
    [Google Scholar]
  32. Su, Y.-H., Yan, X.-T., Oakes, J. E. & Lausch, R. N. ( 1996; ). Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J Virol 70, 1277–1281.
    [Google Scholar]
  33. Tang, Q. & Hendricks, R. L. ( 1996; ). Interferon γ regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J Exp Med 184, 1435–1447.[CrossRef]
    [Google Scholar]
  34. Thomas, J., Gangappa, S., Kanangat, S. & Rouse, B. T. ( 1997; ). On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol 158, 1383–1391.
    [Google Scholar]
  35. Tumpey, T. M., Chen, S. H., Oakes, J. E. & Lausch, R. N. ( 1996; ). Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol 70, 898–904.
    [Google Scholar]
  36. Tumpey, T. M., Cheng, H., Cook, D. N., Smithies, O., Oakes, J. E. & Lausch, R. N. ( 1998a; ). Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. J Virol 72, 3705–3710.
    [Google Scholar]
  37. Tumpey, T. M., Cheng, H., Yan, X.-T., Oakes, J. E. & Lausch, R. N. ( 1998b; ). Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J Leukoc Biol 63, 486–492.
    [Google Scholar]
  38. Wickham, S., Ash, J., Lane, T. E. & Carr, D. J. J. ( 2004; ). Consequences of CXCL10 and IL-6 induction by the murine IFN-α1 transgene in ocular herpes simplex virus type 1 infection. Immunol Res 30, 191–200.[CrossRef]
    [Google Scholar]
  39. Wolpe, S. D., Davatelis, G., Sherry, B. & 7 other authors ( 1988; ). Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 167, 570–581.[CrossRef]
    [Google Scholar]
  40. Zheng, M., Deshpande, S., Lee, S., Ferrara, N. & Rouse, B. T. ( 2001; ). Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol 75, 9828–9835.[CrossRef]
    [Google Scholar]
  41. Zheng, M., Klinman, D. M., Gierynska, M. & Rouse, B. T. ( 2002; ). DNA containing CpG motifs induces angiogenesis. Proc Natl Acad Sci U S A 99, 8944–8949.[CrossRef]
    [Google Scholar]
  42. Zlotnik, A. & Yoshie, O. ( 2000; ). Chemokines: a new classification system and their role in immunity. Immunity 12, 121–127.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81339-0
Loading
/content/journal/jgv/10.1099/vir.0.81339-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error